FAM8A4P

Across TCGA pan-cancer cohorts, FAM8A4P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated FAM8A4P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FAM8A4P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM8A4P expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

KIRC, GBM, and SKCM are the cancer types where FAM8A4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.039	0.632	<.001	36	view →
GBM	OS	Tertile	All	0.160	0.430	.005	27	view →
SKCM	OS	Tertile	III,IV	0.403	0.705	.010	18	view →
CESC	OS	Tertile	All	0.689	0.876	.015	18	view →
COAD	DFS	Tertile	III,IV	0.644	0.310	.022	9	view →
PRAD	OS	Quartile	All	0.968	0.995	.022	8	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FAM8A4P–KIRC (DFS)

Open the KIRC breakdown →